ArticleCancer immunology, immunotherapy : CII2023

IL13Rα2-targeted third-generation CAR-T cells with CD28 transmembrane domain mediate the best anti-glioblastoma efficacy.

Aiqin Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.